Trial · NCT00644449
A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis
NCT00644449, Phase 3, Completed, Pfizer
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis. Trials, record NCT00644449. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00644449
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis
- NCT number
- NCT00644449
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 551 participants, actual
- Lead sponsor
- Pfizer
- Conditions
- Bronchitis, Chronic
- Interventions
- placebo, azithromycin SR (Zithromax; compound: CP-62,993), placebo, levofloxacin
- First posted
- 2008-03-26
- Last updated
- 2011-05-16
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | sponsor assessment of clinical response in the Clinical Per Protocol population | Test of Cure (TOC) visit (Day 14-21) | |
| Secondary | investigator assessment of clinical response in the Clinical Per Protocol population | TOC visit | |
| Secondary | bacteriological response on a per pathogen basis for the Bacteriological Per Protocol population | TOC visit | |
| Secondary | sponsor assessment of clinical response in the Clinical Per Protocol population | Long-Term Follow-Up (LTFU) visit (Day 28-35) | |
| Secondary | Summary of baseline susceptibilities | Study Endpoint | |
| Secondary | adverse events | Continuous | |
| Secondary | clinical laboratory tests | Baseline and EOT visit | |
| Secondary | sponsor assessment of clinical response in the Clinical Per Protocol population | End of Treatment (EOT) visit (Day 8-11) | |
| Secondary | sponsor assessment of clinical response in the remaining study populations | TOC visit | |
| Secondary | sponsor assessment of clinical response by baseline pathogen for the Bacteriological Per Protocol population | EOT visit and TOC visit |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00644449
GET https://conductscience.org/api/trials/v1/NCT00644449/registered